Oryn Therapeutics is a groundbreaking biopharmaceutical company based in Vacaville, CA, dedicated to developing a new class of therapeutics called Orynotides. These innovative drug candidates are designed using the unique properties of theta-defensins found in non-human primates, offering a revolutionary approach to treating complex and difficult-to-treat diseases such as autoimmune and chronic inflammatory conditions, drug-resistant infections, and cancer.
With a focus on improving the quality of life for patients, Oryn Therapeutics aims to create safer and more effective treatments by harnessing the therapeutic potential of Orynotides. These bioinspired therapeutics demonstrate high stability, low toxicity, and low immunogenicity, making them a promising solution for chronic and life-threatening diseases where current treatments have limited efficacy.
Generated from the website